Can I claim acne treatment or eczema relief on skincare sold in the UK?

No, skincare products sold in the UK cannot legally claim acne treatment or eczema relief without proper drug licensing from the MHRA. As an OEM, we formulate compliant products and support testing/documentation, but regulatory approval is your responsibility.

UK buyer view Launch planning Updated: May 6, 2026
Chat on WhatsApp
Best for
US brand owners, Amazon/FBA sellers, distributors, and private label buyers
Core intent
Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

  • In the UK, skincare products fall under cosmetic regulations, which strictly prohibit medicinal claims like treating acne or eczema without registration as a medicine or medical device.
  • This requires approval from the Medicines and Healthcare products Regulatory Agency (MHRA), involving clinical evidence and specific licensing.
  • As your OEM partner, we can develop formulations with cosmetic-grade ingredients and support safety assessments, but we cannot guarantee MHRA approval for drug claims.
  • For standard cosmetic production, MOQ typically starts at 5,000 units per SKU, depending on packaging complexity and formulation costs.
  • Sampling involves 4-6 weeks for initial prototypes, plus 6-8 weeks for mandatory stability testing if you opt for efficacy claims.
  • We assist with microbiological testing, stability checks, and preparing technical documents like the Product Information File (PIF) for UKCA compliance.
  • Packaging must adhere to UK labeling rules, listing all ingredients and avoiding prohibited statements.
  • Lead time from order confirmation to production is around 12-16 weeks, including quality audits and documentation.
  • Always consult a regulatory specialist to validate claims before launch.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).